You are in: eMedicine Specialties > Pediatrics > Nutrition
|
Pellagra Last Updated: June 19, 2006 |
|
| Synonyms and related keywords: pellagra, niacin deficiency, Alpine scurvy, maidism, mal de la rosa, mal rosso, mayidism, psychoneurosis maidica, Saint Ignatius itch, Saint Ignatius' itch, maize, corn
|
|   |
AUTHOR INFORMATION
| Section 1 of 10  |
|
| Author: Kumaravel Rajakumar, MD, Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh |
| Kumaravel Rajakumar, MD, is a member of the following medical societies:
Ambulatory Pediatric Association, and
American Academy of Pediatrics |
| Editor(s): Steven M Schwarz, MD, FAAP, FACN, Chair, Department of Pediatrics, Long Island College Hospital; Professor of Pediatrics, State University of New York, Downstate Medical Center College of Medicine; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc;
Jatinder Bhatia, MD, Professor of Pediatrics, Chief, Section of Neonatology, Vice Chairman for Clinical Research, Department of Pediatrics, Medical College of Georgia;
Merrily P M Poth, MD, Professor, Department of Pediatrics and Neuroscience, Uniformed Services University of the Health Sciences;
and Steven M Altschuler, MD, President and CEO, Children's Hospital Foundation, Children's Hospital of Philadelphia |
Disclosure
|   |
INTRODUCTION
| Section 2 of 10  |
|
Background: Pellagra is a systemic disease of niacin deficiency. Don Gasper Casal, a Spanish court physician, first described pellagra among the poor peasants of the Asturias province of Spain in 1735. In Italian vernacular, pellagra means "rough skin" and refers to the thickened skin noted in patients with pellagra. Pellagra remained endemic among the maize-eating poor peasants of southern Europe for nearly 2 centuries before being recognized in the United States.
Pellagra was reported first in the United States in 1902. Soon, pellagra began to occur in epidemic proportions in the American South. Poverty and dietary consumption of corn were the most frequently observed risk factors. The exact cause of pellagra was not known. Dr. Joseph Goldberger of the US Public Health Service hypothesized that the clinical syndrome was the consequence of an inadequate diet and demonstrated that pellagra could be induced and prevented by dietary modification.
In 1937, Conrad A. Elvehjem, an agricultural chemist at the University of Wisconsin, discovered that nicotinic acid cured black tongue (a condition analogous to pellagra) in dogs. Human clinical trials soon followed and confirmed that nicotinic acid (niacin) represented the key preventive factor to pellagra. Diets based on unfortified maize (corn) are pellagragenic for 2 reasons: (1) These diets are low in tryptophan, the amino acid precursor of niacin and (2) Any endogenous niacin in them is bound and nonbioavailable. Following the discovery of niacin, food fortification with niacin became feasible. Improved socioeconomic conditions, change in dietary practices, and food fortification with niacin were all responsible for the eradication of pellagra from the post–World War II United States.
Despite subsisting on a staple diet of corn, populations of Mexico and Central America have remained essentially pellagra-free. Among these people, the tradition of presoaking maize in alkaline lime prior to cooking liberates bound niacin, enhancing the dietary content of niacin and ensuring protection against pellagra. In contrast, endemic pellagra has been noted among poor peasants of the Deccan Plateau of India who subsist on a staple diet of sorghum (millet). Although this grain contains adequate tryptophan (a precursor of niacin), excessive concentrations of leucine interfere with tryptophan metabolism and subsequent niacin synthesis. Pathophysiology: Niacin is required for adequate cellular function and metabolism as an essential component of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). These compounds are important coenzymes for glycolysis, protein and amino acid metabolism, pyruvate metabolism, pentose biosynthesis, generation of high-energy phosphate bonds, glycerol metabolism, and fatty acid metabolism.
Because cellular functions in multiple organs and tissues are impacted by niacin deficiency, the clinical expression of pellagra is diverse. Pathological changes in the skin include vascular dilatation, proliferation of endothelial lining, perivascular lymphocytic infiltration, and hyperkeratinization and subsequent atrophy of the epidermis. Mucosal inflammation and atrophy involves most of the GI tract. Evidence of glossitis and atrophy of the papillae of the tongue are characteristic findings, along with gastritis and subsequent gastric mucosal atrophy. Acute inflammation of the small intestine and colon also are commonly noted. Pathological changes in the nervous system can be found in the brain, spinal cord, and peripheral nerves. Findings include patchy demyelinization and degeneration of the various affected parts of the nervous system. Frequency:
- In the US: Current incidence of pellagra in the United States is unknown. Epidemics of pellagra no longer occur. Sporadic cases of pellagra could occur among chronic alcoholics, food faddists, and patients with malabsorption states.
- Internationally: Although the exact incidence of pellagra in other countries is not known, chronic seasonal endemic cases of pellagra are observed among the sorghum-eating population of the Deccan Plateau in India.
Mortality/Morbidity: Untreated pellagra results in death from multiorgan failure. Morbidity of pellagra is related to its effects on the various organ systems involved.
- Dermatitis tends to be painful during the acute phase and eventually becomes disfiguring.
- Systemic effects of the disease include malaise, apathy, weakness, and lassitude.
- GI involvement leads to a malabsorptive state and subsequent failure to thrive.
- Neurological manifestations include anxiety, depression, delusions, hallucinations, and stupor.
Race: No racial predilection for the development of pellagra exists, other than its rate of occurrence in ethnic populations with diets deficient in niacin/tryptophan.
Sex: Logically, no sexual predilection for the development of pellagra exists. The only risk factor for development of pellagra should be dietary deprivation of niacin. Epidemiological data collected during the pellagra epidemic in the United States reflect that women, children, and elderly persons of both sexes were the most common individuals affected with pellagra; while infants, adolescents, and working young males were affected least frequently. Such disparity in prevalence resulted from an unbalanced distribution of food within households.
Age: Pellagra typically is an adult disease. Adolescents and young children could develop pellagra if exposed to a pellagragenic diet. Pellagra rarely occurs during infancy. Historically, the dermatitis of Kwashiorkor has been mistaken as infantile pellagra.
|   |
CLINICAL
| Section 3 of 10  |
|
History: Typically, classic pellagra is defined by the 3 Ds: dermatitis, diarrhea, and dementia. Pellagra can be induced experimentally in 6-8 weeks with exposure to a pellagragenic diet. In endemic cases, pellagra tends to be seasonal and occurs during spring and early summer. Early symptoms are nonspecific. Patients express weakness, lassitude, and anorexia. Soon, classic symptoms of dermatitis, mental state disturbances, and GI involvement follow. - Affected skin lesions initially are erythematous and are associated with itching and a burning sensation. The distribution of the cutaneous eruption is typically symmetrical and bilateral on areas prone to sunlight exposure.
- Blistering and vesiculation of affected skin may follow.
- As the dermatitis progresses, the affected skin becomes hyperpigmented and thickened.
- Patients with pellagra tend to suffer from poor appetite, nausea, epigastric discomfort, abdominal pain, and increased salivation.
- Glossitis typically causes soreness of the mouth and dysphagia.
- Diarrhea is the manifestation of GI inflammation. Diarrhea typically is watery but occasionally can be bloody and mucoid.
- Early neuropsychiatric symptoms of pellagra include depression, anxiety, irritability, and poor concentration.
- As the disease advances, patients become disoriented, confused, and delirious. Eventually, the patient becomes stuporous and comatose, and then the patient dies.
Physical: - Typically, the skin lesions of pellagra are represented by a photosensitive dermatitis noted over parts of the body that have been exposed to the sun. They tend to be bilateral and symmetrical in distribution.
- Skin lesions initially resemble a typical sunburn and tend to be symmetrical. Lesions may blister, vesiculate, and denude.
- Eventually, the affected skin thickens and becomes hyperpigmented.
- Parts of the body usually involved include the dorsum of the hands, feet, forearms, and legs; the face presents with a butterfly distribution over the cheeks, forehead, tip of the nose, and front V of the neck. The neck lesion is referred to as the Casal necklace, named after Don Gasper Casal who first described pellagra. Facial seborrheic dermatitis also is observed in some patients. The scrotum, perineum, and pressure points also may be involved.
- Anorexia and malabsorptive diarrhea lead to a state of malnutrition.
- Often, the glossitis is severe and is associated with swelling and tenderness of the tongue. The tongue becomes beefy red and has a raw appearance secondary to atrophy of the papillae.
- Muscle weakness leads to gait problems.
- Paraesthesia and a burning sensation are noted in some patients.
Causes: - Dietary deficiency of niacin or its amino acid precursor tryptophan results in pellagra.
- Dietary amino acid imbalances also are associated with the development of pellagra. Excessive leucine noted in diets in which sorghum is a staple causes an amino acid imbalance, which interferes with tryptophan metabolism resulting in the development of pellagra.
- Risk factors for pellagra genesis include the following:
- Isoniazid therapy: Pyridoxine deficiency secondary to isoniazid treatment could cause pellagra, because pyridoxine is required for the conversion of tryptophan to niacin.
- Other medications: 5-flurouracil, pyrazinamide, 6-mercaptopurine, hydantoins, ethionamide, phenobarbital, azathioprine, and cholramphenicol
- Hartnup disease: This is an inborn error of tryptophan metabolism and a cause of infantile pellagra.
- Prolonged febrile illness
- Neglect and abuse, resulting in malnutrition
- Human immunodeficiency virus (HIV) disease
|   |
DIFFERENTIALS
| Section 4 of 10  |
|
Atopic Dermatitis Contact Dermatitis
Other Problems to be Considered:
Lupus erythematosus in infants and children
Kwashiorkor
Pyridoxine deficiency
Riboflavin deficiency
Seborrheic dermatitis
Vitamin B-12 deficiency |
|
Patient Education
|
|
Click here for patient education.
|
|
|
|
|
|   |
WORKUP
| Section 5 of 10  |
|
Lab Studies:
- Therapeutic response to niacin in a patient with the typical symptoms and signs of pellagra establishes the diagnosis.
- Low serum niacin, tryptophan, NAD levels, and NADP levels can reflect niacin deficiency and confirm the diagnosis of pellagra.
- Low urinary levels of N-methylnicotinamide and pyridone suggest niacin deficiency and support the diagnosis of pellagra. The combined excretion of N-methylnicotinamide and pyridone of less than 1.5 milligrams in 24 hours indicates severe niacin deficiency.
|   |
TREATMENT
| Section 6 of 10  |
|
Medical Care: Nicotinamide or niacin taken orally is usually effective in reversing the clinical manifestations of pellagra. As patients often are malnourished and suffer from other vitamin deficiencies, provision of a high-protein diet and B-complex vitamins is needed for complete restoration of health. Diet: In order to prevent and/or treat pellagra, provide a diet high in protein and adequate in calories. The addition of meats, milk, peanuts, green leafy vegetables, whole or enriched grains, and brewers' dry yeast can enhance the niacin intake. In patients with oral dysphagia secondary to glossitis, a liquid or a semisolid diet may be required. Long-term inclusion of milk, meat, and eggs in the diet ensures dietary adequacy of proteins essential for recovery. Activity: Bed rest is mandatory in treatment of severe cases of pellagra.
|   |
MEDICATION
| Section 7 of 10  |
|
Drug Category: Vitamins -- These are organic substances required by the body in small amounts for various metabolic processes. Vitamins may be synthesized in small or insufficient amounts in the body or not synthesized at all, thus requiring supplementation. Drug Name
| Niacinamide (Vitamin B-3) -- Source of niacin used in tissue respiration, lipid metabolism, and glycogenolysis. Exogenous administration cures the syndrome and, within the dosage levels prescribed, is not associated with uncomfortable flushing observed with niacin administration in other conditions (eg, hypercholesterolemia). |
|---|
| Adult Dose | 100 mg PO q6h for several days or until resolution of major acute symptoms, followed by 50 mg PO q8-12h until all skin lesions heal |
|---|
| Pediatric Dose | 10-50 mg PO q6h until resolution of symptoms and signs |
|---|
| Contraindications | Documented hypersensitivity; active liver disease or unexplained, significant increases in AST and ALT; large doses of niacin, especially when administered in a sustained-release form (associated with severe hepatotoxicity)
Patients who have a definite and recent history of peptic ulcer disease (can reactivate ulcers)| Interactions | Cutaneous vasodilation may be a problem if high dose is used with peripheral dilators (eg, nitroglycerine), taking aspirin 30-60 min before first dose of the day may help alleviate prostaglandin-mediated adverse effects of niacin (eg, flushing, itching); clonidine may inhibit niacin-induced flushing |
|---|
| Pregnancy |
A - Safe in pregnancy
|
|---|
| Precautions | Pregnancy category C if dose >RDA; PO ingestion can be followed by a cutaneous vasodilating phenomenon; flushing reaction is exacerbated if administered in the fasting state; administration in large doses has been associated with gastritis, activation of peptic ulcers, peptic ulcer disease, gout, glucose intolerance, or hepatitis |
|---|
|
|---|
|   |
FOLLOW-UP
| Section 8 of 10  |
|
Further Inpatient Care:
- Patients with acute cases of pellagra require bed rest during the initial phase of treatment.
- Patients with severe glossitis require a liquid or a soft solid diet to overcome the dysphagia.
- Ensure a balanced diet rich in protein and niacin.
- Topical management of skin lesions with emollients may reduce discomfort.
Deterrence/Prevention:
- Avoid sun exposure during active phase of the disease.
- Close dietary follow-up of the patient upon recovery helps prevent recurrence of pellagra.
Complications:
- Dermatitis of pellagra can be distressing and disfiguring. Denudation of the vesiculated and blistered skin lesions potentially can become secondarily infected.
- Severe glossitis causes dysphagia.
- GI involvement leads to a malabsorptive state.
- Depression, anxiety, delusions, hallucinations, and coma are the neuropsychiatric complications observed among patients with pellagra.
- The malnourished state associated with pellagra results in death if untreated.
Prognosis:
- If pellagra is diagnosed and treated appropriately, the prognosis for recovery is excellent.
|   |
MISCELLANEOUS
| Section 9 of 10  |
|
Medical/Legal Pitfalls:
- Individuals with pellagra who present with significant psychiatric manifestations and minimal skin involvement are at risk for misdiagnosis and potential medical/legal liability.
|   |
BIBLIOGRAPHY
| Section 10 of 10 |
|
-
Barakat MR: Pellagra. Monogr Ser World Health Organ 1976; (62): 126-35[Medline].
-
Barness LA: Niacin deficiency. In: Nelson Textbook of Pediatrics. 14th ed. Philadelphia: WB Saunders Company; 1992: 137-138.
-
Carpenter KJ: Pellagra. Benchmark Papers in Biochemistry. Vol 2. Stroudsburg, Pennsylvania: Hutchinson Ross Publishing Company; 1981: 1-391.
-
Etheridge EW: The Butterfly Caste: A Social History of Pellagra in the South. Wesport, CT: Greenwood Publishing Co; 1972: 1-278.
-
Goldsmith GA: Vitamin B complex. Thiamine, riboflavin, niacin, folic acid (folacin), vitamin B12, biotin. Prog Food Nutr Sci 1975; 1(9): 559-609[Medline].
-
Greene HL: Disorders of the water-soluble vitamin B-complex and vitamin C. In: Suskind RM, Lewinter-Suskind L, eds. Textbook of Pediatric Nutrition. 1993: 73-89.
-
Hegyi J, Schwartz RA, Hegyi V: Pellagra: Dermatitis, dementia, and diarrhea. International Journal of Dermatology 2004; 43: 1-5[Medline].
-
Hendricks WM: Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin Dermatol 1991 Dec; 10(4): 282-92[Medline].
-
Marks HM: Epidemiologists explain pellagra: gender, race, and political economy in the work of Edgar Sydenstricker. J Hist Med Allied Sci 2003 Jan; 58(1): 34-55[Medline].
-
Rajakumar K: Pellagra in the United States: a historical perspective. South Med J 2000 Mar; 93(3): 272-7[Medline].
-
Truswell AS: Niacin (nicotinic acid and nicotinamide). In: Davidson's Principles and Practice of Medicine. 13th ed. 1981: 113-116.
Pellagra excerpt |